Trial Profile
Effect of Pitavastatin on the coronary endothelial dysfunction after PCI with DES (Drug-eluting stent)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Mar 2020
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary)
- Indications Coronary artery disease; Coronary artery restenosis; Hypercholesterolaemia
- Focus Pharmacodynamics
- 11 Mar 2020 Status changed from recruiting to completed.
- 30 Nov 2011 Status changed from not yet recruiting to recruiting as reported byUniversity Hospital Medical Information Network - Japan record.
- 26 Apr 2011 New trial record